GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Scaled Net Operating Assets

Henan Lingrui Pharmaceutical Co (SHSE:600285) Scaled Net Operating Assets : 0.30 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Henan Lingrui Pharmaceutical Co's operating assets for the quarter that ended in Mar. 2024 was ¥3,455 Mil. Henan Lingrui Pharmaceutical Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥2,004 Mil. Henan Lingrui Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2023 was ¥4,772 Mil. Therefore, Henan Lingrui Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.30.


Henan Lingrui Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Scaled Net Operating Assets Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.47 0.39 0.35 0.33

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.29 0.37 0.31 0.30

Competitive Comparison of Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets falls into.



Henan Lingrui Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(3272.816-1823.953)/4344.622
=0.33

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4771.917 - 1499.101
=3272.816

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1973.22 - 6.962 - 142.305
=1823.953

Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(3454.833-2003.61)/4771.917
=0.30

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4981.554 - 1526.721
=3454.833

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2039.865 - 7.248 - 29.007
=2003.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henan Lingrui Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
Executives
Wu Xi Zhen Director
Li Jin Supervisors
Ye Qiang senior management
Chen Yan Directors, senior managers
Wu Hui Bin senior management
Yu Peng Director
Zhao Zhi Jun Director
Li Lei senior management
Feng Guo Xin Directors, senior managers
Pan Zi Run Director
Xiong Wei Zheng Director
Tang Wei Supervisors
Cheng Jian Jun Director
Zhang Jun Bing Director
Xia Hui senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines